301. Association between eprosartan-based hypertension therapy and improvement in cognitive function score: long-term follow-up from the OSCAR observational study
- Author
-
Olivier Hanon, Yong Seok Lee, and Atul Pathak
- Subjects
Male ,Medicine (General) ,medicine.medical_specialty ,Systole ,Long term follow up ,Population ,Blood Pressure ,Thiophenes ,Neuropsychological Tests ,Cognition ,R5-920 ,Endocrinology ,Diastole ,Internal medicine ,Internal Medicine ,medicine ,Humans ,Cognitive decline ,education ,Aged ,Demography ,Aged, 80 and over ,education.field_of_study ,business.industry ,Imidazoles ,Eprosartan ,Middle Aged ,Blood pressure ,Acrylates ,Hypertension ,Cohort ,Female ,Observational study ,business ,Follow-Up Studies ,medicine.drug - Abstract
Objective: The Observational Study on Cognitive function And systolic blood pressure Reduction (OSCAR) was designed to evaluate the impact of eprosartan-based therapy on cognitive function in a cohort of 25,745 hypertensive subjects followed for six months. Methods: In this supplementary analysis, we studied the relationship between eprosartan-based therapy and cognitive function (assessed using the Mini-Mental State Examination (MMSE)) after 12-month follow-up of 3600 patients (the long-term follow-up on-treatment population). Results: Reduction in blood pressure was sustained over 12 months, with mean systolic blood pressure/diastolic blood pressure 130.9/79 mmHg at one year, compared with 164.3/92.8 mmHg at baseline ( p
- Published
- 2013
- Full Text
- View/download PDF